DEBORAH BRAY: Open Payments
NPI 1841286143 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 19 payments from 10 companies in 2025. Trend: 2023 $155 · 2024 $442 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| ABIOMED | 2 | $54 |
| Lilly USA, LLC | 2 | $38 |
| Boston Scientific Corporation | 1 | $26 |
| SANOFI PASTEUR INC. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| TOLMAR, INC. | 1 | $14 |
Products named: AIRSUPRA, CAPLYTA, REXULTI, WATCHMAN FLX, MOUNJARO, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, UBRELVY, ONPATTRO.
Industry payments across FL — which companies pay providers there.
